Scientific Sessions 2025  /  Biological and Pragmatic Interventions in Heart Failure: From Present to Future  /  Discussant: ANSWER-HF
Logo

American Heart Association

  110
  0

Final ID:

Discussant: ANSWER-HF

  • Pfeffer, Marc  ( BRIGHAM and WOMENS HOSPITAL , Boston , Massachusetts , United States )
  • Solomon, Scott  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Lopes, Renato  ( DUKE CLINICAL RESEARCH , Durham , North Carolina , United States )
    • Author Disclosures:
    Marc Pfeffer: DO have relevant financial relationships ; Consultant:Alexion:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Novartis:Active (exists now) ; Consultant:Jazz:Past (completed) ; Consultant:Intellia:Active (exists now) ; Individual Stocks/Stock Options:DalCor:Active (exists now) ; Consultant:DalCor:Active (exists now) ; Consultant:AstraZeneca:Active (exists now) | Scott Solomon: DO have relevant financial relationships ; Research Funding (PI or named investigator):Alexion, Alnylam, Applied Therapeutics, AstraZeneca, Bellerophon, Bayer, BMS, Boston Scientific, Cytokinetics, Edgewise, Eidos/BridgeBio, Gossamer, GSK, Ionis, Lilly,NIH/NHLBI, Novartis, NovoNordisk, Respicardia, Sanofi Pasteur, Tenaya, Theracos, US2.AI:Active (exists now) ; Consultant:Abbott, Action, Akros, Alexion, Alnylam, Amgen, Arena, Askbio, AstraZeneca, Bayer, BMS, Cardior, Cardurion, Corvia, Cytokinetics, GSK, Intellia, Lilly, Novartis, Roche, Theracos, Quantum Genomics, Tenaya, Sanofi-Pasteur, Dinaqor, Tremeau, CellProThera, Moderna, American Regent, Sarepta, Lexicon, Anacardio, Akros, Valo, Synhale, Recordati:Active (exists now) | Renato Lopes: DO have relevant financial relationships ; Consultant:Pfizer:Active (exists now) ; Consultant:Medtronic:Past (completed) ; Research Funding (PI or named investigator):Pfizer:Past (completed) ; Research Funding (PI or named investigator):Bristol Myers Squibb:Past (completed) ; Consultant:Bristol Myers Squibb:Active (exists now) ; Consultant:Boehringer Ingelheim:Past (completed) ; Consultant:Bayer:Past (completed) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Daiichi Sankyo:Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Biological and Pragmatic Interventions in Heart Failure: From Present to Future

Sunday, 11/09/2025 , 08:00AM - 09:15AM

Featured Science

More abstracts on this topic:
Discussant: BioVAT-HF DZHK20

Wu Joseph, Margulies Kenneth

Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure - BioVAT-HF-DZHK20 – Phase II Interim Data Report

Ensminger Stephan, Fujita Buntaro, Gerecke Birgit, Hasenfuss Gerd, Hellenkamp Kristian, Herrmann-lingen Christoph, Jebran Ahmad-fawad, Jurczyk Dominik, Kowallick Johannes, Legler Tobias, Lotz Joachim, Kutschka Ingo, Placzek Marius, Puehler Thomas, Riggert Joachim, Sadlonova Monika, Tiburcy Malte, Zimmermann Wolfram, Paitazoglou Christina, Seidler Tim, Brandenburg Soeren, Anker Stefan, Bremmer Felix, Eitel Ingo, Friede Tim

More abstracts from these authors:
The Arc of Heart Failure

Pfeffer Marc

Optimal Anti-Thrombotic Therapy in Acute MI

Lopes Renato

You have to be authorized to contact abstract author. Please, Login
Not Available